Valproate MHRA Guidance: Limitations and Opportunities.

Watkins, Lance; Cock, Hannah; Angus-Leppan, Heather; Morley, Kim; Wilcock, Mike; Shankar, Rohit

Watkins, Lance; Cock, Hannah; Angus-Leppan, Heather; Morley, Kim; Wilcock, Mike; Shankar, Rohit.

Afiliação

Watkins L; Mental Health and Learning Disability Delivery Unit, Llwyneryr Unit, Neath Port Talbot CLDT, Abertawe Bro Morgannwyg University Health Board, Swansea, United Kingdom.
Cock H; Atkinson Morley Regional Neuroscience Centre, St George's University Hospitals NHS Trust, London, United Kingdom.
Angus-Leppan H; Institute of Medical and Biomedical Education, St George's University of London, London, United Kingdom.
Morley K; Epilepsy Initiative Group, Royal Free London, London, United Kingdom.
Wilcock M; University College, London, United Kingdom.
Shankar R; Centre for Research in Public Health and Community Care, University of Hertfordshire, London, United Kingdom.

Front Neurol ; 10: 139, 2019.

Article em En | MEDLINE | ID: mdl-30842753

Palavras-chave

communication; intellectual disability; pregnancy; risk assessment; valproate

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Front Neurol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google